Pharm-Olam International, a multinational, full-service CRO serving the biopharmaceutical and medical device industries, has appointed of Julia Graz as senior director, Biostatistics.

Graz adds over 25 years of progressive pharmaceutical industry experience to the Pharm-Olam team. Her interests and specialties are varied and well-tested. She has worked in biostatistics, programming, data management, pharmacokinetics and quality control. Her multidisciplinary experience spans dozens of pre-clinical and Phase I-IV clinical trials.

“Biostatistics is a key component of our full-service offering,” said Sanjiv Suri, chief executive officer, Pharm-Olam International. “That’s why Julia is such a great addition. Her record is enviable and formidable. I’m confident she’ll be successful in helping us further develop our strategy, create efficiencies, and expand our Biostatistics business unit.”

Pharm-Olam operates in more than 60 countries worldwide, offering end-to-end clinical trial support for phase I-IV clinical trials.